journal article·2017-09Open access

Shape memory polyurethanes with oxidation-induced degradation: In vivo and in vitro correlations for endovascular material applications

Andrew C. Weems, Kevin T. Wacker, James K. Carrow, Anthony J. Boyle, Duncan J. Maitland

Acta Biomaterialia· Volume 59

Abstract

The synthesis of thermoset shape memory polymer (SMP) polyurethanes from symmetric, aliphatic alcohols and diisocyanates has previously demonstrated excellent biocompatibility in short term in vitro and in vivo studies, although long term stability has not been investigated. Here we demonstrate that while rapid oxidation occurs in these thermoset SMPs, facilitated by the incorporation of multi-functional, branching amino groups, byproduct analysis does not indicate toxicological concern for these materials. Through complex multi-step chemical reactions, chain scission begins from the amines in the monomeric repeat units, and results, ultimately, in the formation of carboxylic acids, secondary and primary amines; the degradation rate and product concentrations were confirmed using liquid chromatography mass spectrometry, in model compound studies, yielding a previously unexamined degradation mechanism for these biomaterials. The rate of degradation is dependent on the hydrogen peroxide concentration, and comparison of explanted samples reveals a much slower rate in vivo compared to the widely accepted literature in vitro real-time equivalent of 3% H2O2. Cytotoxicity studies of the material surface, and examination of the degradation product accumulations, indicate that degradation has negligible impact on cytotoxicity of these materials. Statement of significance This paper presents an in-depth analysis on the degradation of porous, shape memory polyurethanes (SMPs), including traditional surface characterization as well as model degradation compounds with absolute quantification. This combination of techniques allows for determination of rates of degradation as well as accumulation of individual degradation products. These behaviors are used for in vivo-in vitro comparisons for determination of real time degradation rates. Previous studies have primarily been limited to surface characterization without examination of degradation products and accumulation rates. To our knowledge, our work presents a unique example where a range of material scales (atomistic-scale model compounds along with macroscopic porous SMPs) are used in conjunction with ex planted samples for calculation of degradation rates and toxicological risk.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Polymer composites and self-healing · Carbon dioxide utilization in catalysis · Marine Biology and Environmental Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Comparative analysis of in vitro oxidative degradation of poly(carbonate urethanes) for biostability screening10.1002/jbm.a.35037 ↗
2. Biodegradation mechanisms of polyurethane elastomers10.1179/174327807X238909 ↗
3. Limitations of predicting in vivo biostability of multiphase polyurethane elastomers using temperature-accelerated degradation testing10.1002/jbm.b.33161 ↗
4. Degradable polyester scaffolds with controlled surface chemistry combining minimal protein adsorption with specific bioactivation10.1038/nmat2904 ↗
5. A porous tissue engineering scaffold selectively degraded by cell-generated reactive oxygen species10.1016/j.biomaterials.2014.01.026 ↗
6. Local iontophoretic administration of cytotoxic therapies to solid tumors
7. Polyurethane foam-covered breast-implants: a justified choice?
8. United States General Accounting Office. Medical Technology, For some cardiac pacemaker leads, the public health risks are still high. (September 23, 1992). http://www.gao.gov/assets/220/216942.pdf.
9. Incidence and costs related to lead damage occurring within the first year after a cardiac implantable electronic device replacement procedure10.1161/JAHA.115.002813 ↗
10. Failure of a novel silicone-polyurethane copolymer (OptimTM) to prevent implantable cardioverter-defibrillator lead insulation abrasions10.1093/europace/eus245 ↗
11. Polyurethane-coated breast implants revisited: a 30 year follow up10.5999/aps.2015.42.2.186 ↗
12. Pathology of lymph nodes from patients with breast implants10.1097/01.pas.0000155145.60670.e4 ↗
13. Toxic hydrolysis product from a biodegradable foam implant10.1002/jbm.820231406 ↗
14. Foam-covered mammary implants
15. Back to the future: a 15-year experience with polyurethane foam-covered breast implants using the partial-subfascial technique10.1007/s00266-011-9826-5 ↗
16. Canadian incidence in a cohort: extended follow-up of cancer incidence10.1002/ijc.27603 ↗
17. Shape memory polymer network with thermally distinct elasticicty and plasticity10.1126/sciadv.1501297 ↗
18. Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials10.1016/j.biomaterials.2005.05.079 ↗
19. Antioxidant inhibition of poly(carbonate urethane) in vivo biodegradation10.1002/jbm.a.30506 ↗
20. Oxidative and enzymatic degradations of L-tyrosine based polyurethanes10.1016/j.polymdegradstab.2007.08.003 ↗
21. Assessment of the degradation of polyurethane foams after artificial and natural ageing by using pyrolysis-gas chromatography/mass spectrometry and headspace-solid phase microextraction-gas chromatography/mass spectrometry10.1016/j.chroma.2011.05.013 ↗
22. Shape memory polymers based on uniform aliphatic urethane networks10.1002/app.26593 ↗
23. Examination of radio-opacity enhancing additives in shape memory polyurethane foams10.1002/app.42054 ↗
24. Low density biodegradable shape memory polyurethane foams for embolic biomedical applications10.1016/j.actbio.2013.09.027 ↗
25. Ultra low density and highly crosslinked biocompatible shape memory polymer foams10.1002/polb.23056 ↗
26. Shape memory polymers with enhanced visibility for magnetic resonance and x-ray imaging modalities10.1016/j.actbio.2017.02.045 ↗
27. Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery10.1038/nmat3187 ↗
28. Mild catalytic oxidation of secondary and tertiary amines to nitrones and N-oxides with H2O2 mediated by Pt (II) catalysts10.1039/b805404e ↗
29. A metal-free general procedure for oxidation of secondary amines to nitrones10.1021/jo901108u ↗
30. Oxidation of primary amines to oximes with molecular oxygen using 1,1-diphenyl-2-picrylhydrazyl and WO3/Al2O2 as catalysts10.1021/jo302262a ↗
31. Mild and efficient Flavin-catalyzed H2O2 oxidation of tertiary amines to amine N-oxides10.1021/jo980926d ↗
32. Copper-catalyzed oxidative amidation of aldehydes with amine salts: synthesis of primary, secondary, and tertiary amines10.1021/jo301252c ↗
33. Surface-mediated reactions. 9. Selective oxidation of primary and secondary amines to hydroxylamines10.1021/jo0002083 ↗
34. Metal-organic frameworks with precisely designed interior for carbon dioxide capture in the presence of water10.1021/ja503296c ↗
35. Enhancing the biocompatibility and biodegradability of linear poly(ethylene imine) through controlled oxidation10.1021/acs.macromol.5b01940 ↗
36. Optimization of normal-phase chromatographic separation of compounds with primary, secondary, and tertiary amino groups10.1016/j.chroma.2008.04.052 ↗
37. Amine scrubbing for CO2 capture
38. In vivo response to an implanted shape memory polyurethane foam in a porcine aneurysm model10.1002/jbm.a.34782 ↗
39. Removing fresh tissue from explanted polyurethane prostheses: which approach facilitates physico-chemical analysis?10.1016/0142-9612(95)93854-7 ↗
40. Durability of a polymer with triple-shape properties10.1016/j.polymdegradstab.2010.07.037 ↗
41. Hydrolytic degradation and functional stability of a segmented shape memory poly(ester urethane)10.1016/j.polymdegradstab.2008.10.012 ↗
42. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems10.1016/S0168-3659(01)00502-8 ↗
43. Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction10.1007/s10439-013-0933-0 ↗
44. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
45. Health Council of the Netherlands: Committeee on Updating of Occupational Exposure Limits · 2004
46. Mechanism of calcium oxalate renal stone formation and renal tubular cell injury10.1111/j.1442-2042.2007.01953.x ↗
47. Regulation of dendrimer/dextran material performance by altered tissue microenvironment in inflammation and neoplasia
48. Review of adaptive programmable materials and their bioapplications10.1021/acsami.6b09110 ↗
49. Control of PLA stereoisomers-based polyurethane elastomers as highly efficient shape memory materials10.1021/acssuschemeng.6b02652 ↗
50. Healing with medical implants: the body battles back